STOCK TITAN

Agenus Inc. (AGEN) awards 50,000 stock options to director Wright

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Agenus Inc. reported that director Timothy Wright received a grant of 50,000 stock options under its 2019 Amended and Restated Equity Incentive Plan. The options have an exercise price of $7.78 per share, expire on August 5, 2036, and vest over three years with one-third after one year and the remainder in two equal annual installments.

Positive

  • None.

Negative

  • None.
Insider Wright Timothy
Role Director
Type Security Shares Price Value
Grant/Award Stock Option F1 50,000 $0.00 $0.00
Holdings After Transaction: Stock Option — 50,000 shares (Direct)
Footnotes (1)
  1. F1. Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vest over three (3) years, with one-third (1/3) vesting on the first anniversary of the Grant Date and the remaining two-thirds (2/3) vesting in two equal annual installments thereafter.
Stock options granted 50,000 options Grant of stock options to director Timothy Wright on August 5, 2026
Exercise price $7.78 per share Exercise price for the 50,000 granted stock options
Underlying shares 50,000 shares Underlying Agenus common stock for the option grant
Expiration date August 5, 2036 Option term for the granted stock options
Stock Option financial
"The reporting person received a grant of Stock Option covering common stock."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
Equity Incentive Plan financial
"Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan."
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
vesting financial
"The options vest over three years, with one-third vesting after one year."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
exercise price financial
"The options have an exercise price of $7.78 per share."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"The options carry an expiration date of August 5, 2036."
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Agenus (AGEN) report for Timothy Wright?

Agenus reported that director Timothy Wright received a grant of 50,000 stock options. These options relate to Agenus common stock and were awarded as part of his compensation under the company’s 2019 Amended and Restated Equity Incentive Plan.

What is the exercise price of Timothy Wright’s new Agenus (AGEN) stock options?

The granted options have an exercise price of $7.78 per share. This is the price at which Wright can buy Agenus common stock if he exercises the options, subject to the vesting schedule and option term.

How many Agenus (AGEN) shares underlie Timothy Wright’s option grant?

The option grant covers 50,000 shares of Agenus common stock as the underlying security. Exercising all options, once vested, would allow acquisition of up to 50,000 Agenus common shares at the stated exercise price.

When do Timothy Wright’s Agenus (AGEN) stock options vest?

The options vest over three years: one-third vests on the first anniversary of the grant date, with the remaining two-thirds vesting in two equal annual installments thereafter, assuming continued service under the plan’s terms.

What is the expiration date of Timothy Wright’s Agenus (AGEN) option grant?

The stock options are scheduled to expire on August 5, 2036. After this expiration date, any unexercised portion of the options will lapse and can no longer be used to acquire Agenus common stock.

Under which plan were Timothy Wright’s Agenus (AGEN) options granted?

The options were awarded under the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan. This plan governs the terms of equity awards, including vesting, exercise conditions, and other requirements for participants.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Wright Timothy

(Last)(First)(Middle)
C/O AGENUS INC.
3 FORBES ROAD

(Street)
LEXINGTON MASSACHUSETTS 02421

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
AGENUS INC [ AGEN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/05/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option$7.7808/05/2026A50,000 (1)08/05/2036Common Stock50,000$0.0050,000D
Explanation of Responses:
1. Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vest over three (3) years, with one-third (1/3) vesting on the first anniversary of the Grant Date and the remaining two-thirds (2/3) vesting in two equal annual installments thereafter.
/s/Melissa Orilall, as Attorney-in-Fact for Timothy Wright08/07/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)